Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Parkinson’s Disease: Ripe For A Rethink

Developments In A Burgeoning Market

Jul 04 2023

• By Jo Shorthouse

Brain jigsaw — Cases of Parkinson's Disease expected to increase by 30.8% worldwide between 2018 and 2027

Related Content

NeuroDerm Parkinson’s Drug Inches Closer To Market With Phase III Win

Jan 09 2023

Irlab Parkinson's Pact With Ipsen Up In The Air

Jan 18 2023

Aptinyx Pulls Back From Neuropsychiatry After Mid-Stage PD Failure

Mar 01 2023

Manus Neurodynamica: Catching Up With A 2022 Rising Leader

Jun 21 2023

Novartis Will Co-Develop UCB’s Alpha-Syn Inhibitor For Parkinson’s

Dec 02 2021

Path Ahead For Neuraly’s NLY01 Unclear After Phase II Parkinson’s Disappointment

Mar 28 2023

Additional Topics

Clinical Trials Innovation New Science Research & Development Neurology BioPharmaceutical

More from Innovation

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window